191 related articles for article (PubMed ID: 29466294)
1. Respiratory-gated Proton Beam Therapy for Hepatocellular Carcinoma Adjacent to the Gastrointestinal Tract without Fiducial Markers.
Mizuhata M; Takamatsu S; Shibata S; Bou S; Sato Y; Kawamura M; Asahi S; Tameshige Y; Maeda Y; Sasaki M; Kumano T; Kobayashi S; Yamamoto K; Tamamura H; Gabata T
Cancers (Basel); 2018 Feb; 10(2):. PubMed ID: 29466294
[TBL] [Abstract][Full Text] [Related]
2. Proton Beam Therapy without Fiducial Markers Using Four-Dimensional CT Planning for Large Hepatocellular Carcinomas.
Shibata S; Takamatsu S; Yamamoto K; Mizuhata M; Bou S; Sato Y; Kawamura M; Asahi S; Tameshige Y; Maeda Y; Sasaki M; Kumano T; Kobayashi S; Tamamura H; Gabata T
Cancers (Basel); 2018 Mar; 10(3):. PubMed ID: 29538310
[TBL] [Abstract][Full Text] [Related]
3. Long-Term Results of Proton Therapy for Hepatocellular Carcinoma Using Four-Dimensional Computed Tomography Planning without Fiducial Markers.
Bou S; Takamatsu S; Matsumoto S; Asahi S; Tatebe H; Sato Y; Kawamura M; Shibata S; Kondou T; Tameshige Y; Maeda Y; Sasaki M; Yamamoto K; Sunagozaka H; Aoyagi H; Tamamura H; Kobayashi S; Gabata T
Cancers (Basel); 2022 Nov; 14(23):. PubMed ID: 36497323
[TBL] [Abstract][Full Text] [Related]
4. Ablative dose proton beam therapy for stage I and recurrent non-small cell lung carcinomas : Ablative dose PBT for NSCLC.
Lee SU; Moon SH; Cho KH; Pyo HR; Kim JY; Kim DY; Kim TH; Suh YG; Kim YJ
Strahlenther Onkol; 2016 Sep; 192(9):649-57. PubMed ID: 27282279
[TBL] [Abstract][Full Text] [Related]
5. Phase II Study of Hypofractionated Proton Beam Therapy for Hepatocellular Carcinoma.
Kim TH; Park JW; Kim BH; Oh ES; Youn SH; Moon SH; Kim SS; Woo SM; Koh YH; Lee WJ; Kim DY
Front Oncol; 2020; 10():542. PubMed ID: 32411594
[No Abstract] [Full Text] [Related]
6. Proton beam therapy for hepatocellular carcinoma with bile duct invasion.
Iizumi T; Okumura T; Hasegawa N; Ishige K; Fukuda K; Seo E; Makishima H; Niitsu H; Takahashi M; Sekino Y; Takahashi H; Takizawa D; Oshiro Y; Baba K; Murakami M; Saito T; Numajiri H; Mizumoto M; Nakai K; Sakurai H
BMC Gastroenterol; 2023 Aug; 23(1):267. PubMed ID: 37537527
[TBL] [Abstract][Full Text] [Related]
7. Proton beam therapy for large hepatocellular carcinoma.
Sugahara S; Oshiro Y; Nakayama H; Fukuda K; Mizumoto M; Abei M; Shoda J; Matsuzaki Y; Thono E; Tokita M; Tsuboi K; Tokuuye K
Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):460-6. PubMed ID: 19427743
[TBL] [Abstract][Full Text] [Related]
8. Clinical Outcomes of Proton Beam Therapy for Choroidal Melanoma at a Single Institute in Korea.
Kim TW; Choi E; Park J; Shin DH; Jung SK; Seok S; Cho KH; Kim JY; Kim DY; Kim TH; Suh YK; Kim YJ; Moon SH
Cancer Res Treat; 2018 Apr; 50(2):335-344. PubMed ID: 28421723
[TBL] [Abstract][Full Text] [Related]
9. Clinical results of proton beam therapy for hepatocellular carcinoma over 5 cm.
Kimura K; Nakamura T; Ono T; Azami Y; Suzuki M; Wada H; Takayama K; Endo H; Takeyama T; Hirose K; Takai Y; Kikuchi Y
Hepatol Res; 2017 Dec; 47(13):1368-1374. PubMed ID: 28198132
[TBL] [Abstract][Full Text] [Related]
10. Clinical assessment of coiled fiducial markers as internal surrogates for hepatocellular carcinomas during gated stereotactic body radiotherapy with a real-time tumor-tracking system.
Hanazawa H; Takahashi S; Shiinoki T; Park SC; Yuasa Y; Koike M; Kawamura S; Shibuya K
Radiother Oncol; 2017 Apr; 123(1):43-48. PubMed ID: 28285839
[TBL] [Abstract][Full Text] [Related]
11. Proton Beam Therapy for Hepatocellular Carcinoma: Multicenter Prospective Registry Study in Japan.
Mizumoto M; Ogino H; Okumura T; Terashima K; Murakami M; Ogino T; Tamamura H; Akimoto T; Waki T; Katoh N; Araya M; Onoe T; Takagi M; Iwata H; Numajiri H; Okimoto T; Uchinami Y; Maruo K; Shibuya K; Sakurai H
Int J Radiat Oncol Biol Phys; 2024 Mar; 118(3):725-733. PubMed ID: 37778422
[TBL] [Abstract][Full Text] [Related]
12. A phase II trial of hypofractionated high-dose proton beam therapy for unresectable liver metastases.
Kim K; Yu JI; Park HC; Yoo GS; Lim DH; Noh JM; Jeong WK
Radiother Oncol; 2022 Nov; 176():9-16. PubMed ID: 36113779
[TBL] [Abstract][Full Text] [Related]
13. Proton Beam Therapy in Managing Unresectable Hepatocellular Carcinoma with Bile Duct Invasion.
Lee CH; Chen AH; Hung SP; Hsieh CE; Tseng JH; Chen PJ; Cheng JY; Chang JT; Chan KM; Lin SM; Lin CC; Chen WT; Chen WY; Huang BS
Cancers (Basel); 2022 Mar; 14(7):. PubMed ID: 35406392
[TBL] [Abstract][Full Text] [Related]
14. Proton beam therapy for extrahepatic biliary tract cancer: Analysis with prospective multi-institutional patients' registration database, Proton-Net.
Yamazaki H; Shibuya K; Kimoto T; Suzuki M; Murakami M; Terashima K; Okimoto T; Iizumi T; Sakurai H; Wakatsuki M; Suzuki O; Katoh N; Arimura T; Ogino T; Takagi M; Araya M; Waki T; Matsumoto S; Ogino H; Fukumoto T; Ohtsuka M
Clin Transl Radiat Oncol; 2023 Jul; 41():100634. PubMed ID: 37234735
[TBL] [Abstract][Full Text] [Related]
15. Does Risk-Adapted Proton Beam Therapy Have a Role as a Complementary or Alternative Therapeutic Option for Hepatocellular Carcinoma?
Kim TH; Park JW; Kim BH; Kim H; Moon SH; Kim SS; Woo SM; Koh YH; Lee WJ; Kim DY; Kim CM
Cancers (Basel); 2019 Feb; 11(2):. PubMed ID: 30781391
[TBL] [Abstract][Full Text] [Related]
16. Phase I dose-escalation study of proton beam therapy for inoperable hepatocellular carcinoma.
Kim TH; Park JW; Kim YJ; Kim BH; Woo SM; Moon SH; Kim SS; Koh YH; Lee WJ; Park SJ; Kim JY; Kim DY; Kim CM
Cancer Res Treat; 2015 Jan; 47(1):34-45. PubMed ID: 25381830
[TBL] [Abstract][Full Text] [Related]
17. Clinical Outcomes and Prognostic Factors of High-Dose Proton Beam Therapy for Peripheral Stage I Non-Small-Cell Lung Cancer.
Hatayama Y; Nakamura T; Suzuki M; Azami Y; Ono T; Yabuuchi T; Hayashi Y; Kimura K; Hirose K; Wada H; Hareyama M; Kikuchi Y; Takai Y
Clin Lung Cancer; 2016 Sep; 17(5):427-432. PubMed ID: 26725851
[TBL] [Abstract][Full Text] [Related]
18. Initial clinical outcomes of proton beam radiotherapy for hepatocellular carcinoma.
Yu JI; Yoo GS; Cho S; Jung SH; Han Y; Park S; Lee B; Kang W; Sinn DH; Paik YH; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Park HC
Radiat Oncol J; 2018 Mar; 36(1):25-34. PubMed ID: 29580046
[TBL] [Abstract][Full Text] [Related]
19. Proton beam therapy outcomes for localized unresectable hepatocellular carcinoma.
Chadha AS; Gunther JR; Hsieh CE; Aliru M; Mahadevan LS; Venkatesulu BP; Crane CH; Das P; Herman JM; Koay EJ; Taniguchi C; Holliday EB; Minsky BD; Suh Y; Park P; Sawakuchi G; Beddar S; Odisio BC; Gupta S; Loyer E; Kaur H; Raghav K; Javle MM; Kaseb AO; Krishnan S
Radiother Oncol; 2019 Apr; 133():54-61. PubMed ID: 30935582
[TBL] [Abstract][Full Text] [Related]
20. Recent update of proton beam therapy for hepatocellular carcinoma: A systematic review and meta-analysis.
Bae SH; Jang WI; Mortensen HR; Weber B; Kim MS; Høyer M
J Liver Cancer; 2024 Jul; ():. PubMed ID: 38961722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
